RLAY – relay therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Relay Therapeutics (RLAY) is now covered by JonesTrading. They set a "hold" rating and a $18.00 price target on the stock.
Relay Therapeutics (RLAY) had its "sell (d-)" rating reaffirmed by Weiss Ratings.
Relay Therapeutics (RLAY) had its price target raised by Barclays PLC from $17.00 to $21.00. They now have an "overweight" rating on the stock.
Relay Therapeutics (RLAY) Surges 16.4%: Is This an Indication of Further Gains? [Yahoo! Finance]
Relay Therapeutics (RLAY) Is Up 30.6% After Expanding Zovegalisib Into Vascular Anomalies Data Reveal [Yahoo! Finance]
Form PRE 14A Relay Therapeutics, Inc. For: Jun 09
Form SCHEDULE 13G Relay Therapeutics, Inc. Filed by: PERCEPTIVE ADVISORS LLC
Form 4 Relay Therapeutics, Inc. For: Apr 07 Filed by: Catinazzo Thomas
Form SCHEDULE 13G/A Relay Therapeutics, Inc. Filed by: VANGUARD GROUP INC
Form SCHEDULE 13G Relay Therapeutics, Inc. Filed by: PERCEPTIVE ADVISORS LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.